ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 30 filers reported holding ACHILLES THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $588,000 | -17.8% | 233,180 | -4.2% | 0.01% | -25.0% |
| Q1 2022 | $715,000 | -56.0% | 243,296 | -25.0% | 0.01% | -47.8% |
| Q4 2021 | $1,625,000 | +114.4% | 324,387 | +319.2% | 0.02% | +64.3% |
| Q2 2021 | $758,000 | -80.8% | 77,386 | -67.6% | 0.01% | -84.1% |
| Q1 2021 | $3,953,000 | – | 238,822 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,014,687 | $49,094,000 | 0.79% |
| Boxer Capital, LLC | 1,536,016 | $15,038,000 | 0.53% |
| Artal Group S.A. | 2,255,375 | $22,080,000 | 0.45% |
| Redmile Group, LLC | 2,088,089 | $20,442,000 | 0.30% |
| Affinity Asset Advisors, LLC | 80,000 | $783,000 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 292,194 | $2,861,000 | 0.19% |
| Orbimed Advisors | 1,584,845 | $15,516,000 | 0.16% |
| Baker Brothers Advisors | 2,591,366 | $25,369,000 | 0.11% |
| Perceptive Advisors | 1,510,750 | $14,790,000 | 0.10% |
| Monashee Investment Management LLC | 64,697 | $633,000 | 0.08% |